Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. The Company organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Its diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Its bio Supplies provides, mostly, biological products for non-therapeutic use.
äŒæ¥ã³ãŒãGRFS
äŒç€ŸåGrifols SA
äžå Žæ¥May 17, 2006
æé«çµå¶è²¬ä»»è
ãCEOãAbia (Jose Ignacio)
åŸæ¥å¡æ°23833
蚌åžçš®é¡Depository Receipt
æ±ºç®ææ«May 17
æ¬ç€Ÿæåšå°Parque Empresarial Can Sant Joan
éœåžSANT CUGAT DEL VALLES
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœSpain
éµäŸ¿çªå·08174
é»è©±çªå·34935710000
ãŠã§ããµã€ãhttps://www.grifols.com/
äŒæ¥ã³ãŒãGRFS
äžå Žæ¥May 17, 2006
æé«çµå¶è²¬ä»»è
ãCEOãAbia (Jose Ignacio)